STUART L. FINE, M.D

William F. Norris and George E. deSchweinitz
Professor of Ophthalmology
Chairman, Department of Ophthalmology
Director, Scheie Eye Institute
University of Pennsylvania, Philadelphia

Education

University of Maryland, College Park B.A. 1958-1962 Philosophy
University of Maryland, Baltimore M.D. 1962-1966 Medicine
University of Maryland Hospital, Baltimore Internship 1966-1967 Medicine
U.S. Public Health Service Military 1967-1969 Lt. Commander
University of Florida, Gainesville Residency 1969-1972 Ophthalmology
The Johns Hopkins University, Baltimore Fellowship 1972-1973 NIH Special Fellow


Faculty Appointments

1973-1990 The Wilmer Ophthalmological Institute, The Johns Hopkins University School of Medicine

1974-1990 Director of Undergraduate Education in Ophthalmology, The Johns Hopkins University School of Medicine

1976-1983 Fellowship Program Director, Retinal Vascular Center, The Johns Hopkins University School of Medicine

1979-1990 Director, Retinal Vascular Center, The Wilmer Institute, The Johns Hopkins University School of Medicine

1982-1990 Professor of Ophthalmology, The Johns Hopkins University School of Medicine

1991-present Chairman, Professor of Ophthalmology, and Director of the Scheie Eye Institute, The University of Pennsylvania School of Medicine, Philadelphia


Selected NIH Grant Support

1979-1994 Study Chair, Macular Photocoagulation Study (16 clinical centers; documented benefit of laser treatment for selected patients with neovascular stage of age-related macular degeneration)

1985-present Study Chair, Collaborative Ocular Melanoma Study (43 clinical centers; ongoing evaluation of management strategies for patients with eye melanoma)

1994-1999 Study Chair, Choroidal Neovascularization Prevention Trial (16 clinical centers; pilot trial to evaluate preventive treatment for early stage of age-related macular degeneration)

1999- Study Chair, Complications of AMD Prevention Trial (22 clinical centers; definitive trial to evaluate preventive treatment for early stage of age-related macular degeneration

2000- Principal Investigator and Study Chair, AMD and Radiotherapy Trial (12 clinical centers; pilot trial to assess radiation treatment for neovascular stage of age-related macular degeneration)

Selected Honors

1982 Professors' Award for Excellence in Teaching, The Johns Hopkins University School of Medicine

1995 J. Donald M. Gass, M.D. Award for Outstanding Contributions to Macular Research, Macula Society

1996 Retina Research Fund Award of Merit (Awarded by the Retina Research Fund and the Retina Society for Lifetime Contributions to Retina Research)

1998-2000 President, Association of University Professors of Ophthalmology

2000  Sir Norman Gregg Medal, Royal Australian and New Zealand College of Ophthalmology

Selected Publications 1994-present

Bressler NM, Silva JC, Bressler SB, Fine SL, Green WR.  Clinicopathologic correlation of drusen and retinal pigment epithelial abnormalities in age-related macular degeneration.  Retina 14:130-142, 1994.

Macular Photocoagulation Study Group: Five-year follow-up of fellow eyes of individuals with ocular histoplasmosis and unilateral extrafoveal or juxtafoveal choroidal neovascularization.  Arch Ophthalmol, 114(6):677-688, 1996.

Macular Photocoagulation Study Group (prepared by Bressler NM, Marsh MJ, Maguire MG, Alexander J, Phillips DA, Javornik NB, Hiner ML, Lewis ML, Schachat AP, Singerman LJ, Stevens TS, Hawkins BS, Fine SL).  Occult choroidal neovascularization: Influence on visual outcome in patients with age-related macular degeneration.  Arch Ophthalmol, 114(4):400-12, 1996 Apr.

Fine SL.  No one knows the preferred management for choroidal melanoma.  (Editorial).  Am. J. Ophthalmology 122(1):106-108, 1996.

Stevens TS, Bressler NM, Maguire MG, Bressler SB, Fine SL, et al: Occult choroidal neovascularization in age-related macular degeneration: A natural history study of morphologic changes.  Arch Ophthalmol. 115:345-350, 1997.

Macular Photocoagulation Study Group: Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Arch Ophthalmol.,115:741-747, 1997.

Collaborative Ocular Melanoma Study Group. COMS Report No. 4.   Mortality in patients with small choroidal melanoma.  Arch Ophthalmol., 115:886-893, 1997.

Fine SL, Maguire MG.  We are very spoiled. (Editorial).  Arch Ophthalmol., 115:915-916, 1997.

Collaborative Ocular Melanoma Study Group.  COMS Report No. 5.  Factors Predictive of Growth and Treatment of Small Choroidal Melanoma.  Arch Ophthalmol., 115:1537-1544, 1997.

Choroidal Neovascularization Prevention Trial Research Group (prepared by Maguire MG, Fine SL, Ho AC, Javornik NB).  Laser treatment in eyes with large drusen: short term effects from a pilot randomized clinical trial.  Ophthalmol. 105:11-23, 1998.

Collaborative Ocular Melanoma Study Group.  COMS Report No. 10. Randomized trial of pre-enucleation radiation of large choroidal melanoma II: Initial mortality findings.  Am. J. Ophthalmol. 125: 779-796, 1998.

Lanchoney DM, Maguire MG, Fine SL. A model of incidence and consequences of choroidal neovascularization secondary to age-related macular degeneration. Arch Ophthalmol., 116: 1045-1052, 1998.

Berger, JW, Fine SL, Maguire MG Age-related Macular Degeneration (textbook), CV Mosby Co., 1998

Fine SL.  Macular Hole:  A Continuing Saga.  (Editorial) Arch Ophthalmol., 117:  248-249, 1999.

Fine SL, Berger JW, Maguire MG, Ho AC.  Age-related macular degeneration.  The New England Journal of Medicine, 342:7,483, 1999.

Kaiser RS, Maguire MG, Grunwald JE, Lieb D, Jani B, Brucker AJ, Maguire AM, Ho AC, Fine, SL.  One-year outcomes of panretinal photocoagulation in proliferative diabetic retinopathy.  Am. J. Ophthalmol., 129:178-185, 2000.

Fine, SL and Maguire, MG.  It is not time to abandon radiotherapy for neovascular age-related macular degeneration.  (Editorial) Arch Ophthalmol. 119: 275-276, 2001

Kaiser RS, Berger JW, Maguire MG, Shin DS, Ho AC, Javornik NB, Fine SL and the Choroidal Neovascularization Prevention Trial Research Group.  Laser burn intensity and the risk for choroidal neovascularization in the CNVPT Fellow Eye Study.  Arch. Ophthalmology, 119: 826-832, 2001.